Hepatitis Clinical Trials

Showing 721-740 of 2,113 trials

Effects of Health Literacy and HCV Knowledge on HCV Treatment Willingness in HIV-coinfected Patients

NCT03413696

A clinical observational study for patients with HIV co-infected with hepatitis C that investigates the levels of their health literacy, hepatitis C and HIV knowledge. Participants will complete a one-time assessment of these studied domains and categorized in three groups defined by their hepatitis C treatment referral status: not-referred, referred-attended, referred and no-show.

Hepatitis CHepatitis C, ChronicHIV/AIDS

University of California, San Diego150 participantsStarted Sep 2017

San Diego, California, United States

UNKNOWN

Radiomics for Diagnosing Liver Diseases and Evaluating Progression

NCT03221049

Liver diseases are worldwide problems. liver fibrosis and hepatocellular carcinoma are mostly concerned by clinicians. Radiomcis can improve diagnosis accuracy and evaluate disease progression. Hence,investors try to combine radiomics and ultrasound images together in order to improve diagnosis performances of liver fibrosis, benign and malignant tumor and progression after liver ablations.

Hepatitis B / Liver Space-occupying Lesions / Patients After Ablation

Third Affiliated Hospital, Sun Yat-Sen University3,000 participantsStarted Jan 2011

Guangzhou, Guangdong, China

COMPLETEDPhase 3

High-dose IFN and PEG IFN for Induction Therapy in Difficult to Treat Genotype 1 Patients With Chronic HCV

NCT00381953

Comparison of virological breakthrough/relapse rate after dose adjustments and sustained virological response rate will be assessed by the type of induction.

Hepatitis C

Foundation for Liver Research33 participantsStarted Feb 2003

Rotterdam, Netherlands

TERMINATED

Study of Daclatasvir-based Therapy in Chinese Participants With Chronic Hepatitis C (CHC)

NCT03500562

Study is a non-interventional, prospective, multicenter post marketing surveillance study to determine the safety of daclatasvir based therapy

Chronic Hepatitis C

Bristol-Myers Squibb3 participantsStarted May 2018

Beijing, Beijing Municipality, China • Guangzhou, Guangdong, China

Effects of Health Literacy and HCV Knowledge on HCV Treatment Willingness in HIV-coinfected Patients

Radiomics for Diagnosing Liver Diseases and Evaluating Progression

High-dose IFN and PEG IFN for Induction Therapy in Difficult to Treat Genotype 1 Patients With Chronic HCV

Study of Daclatasvir-based Therapy in Chinese Participants With Chronic Hepatitis C (CHC)

Related Searches

Evaluation of Intradermal Hepatitis B Vaccine After IMIQUIMOD's Application, in Cirrhotics Who Did Not Respond to the Usual Vaccine Regimen

HCV Reinfection After DAA Therapy in PWID in Belgium

Effects of ACC Inhibitor on Lipid and Lipoprotein Metabolism

Predictive Model for Prognosis of Chronic HBV Infection Mothers

Improving Inpatient Screening for Hepatitis C

The Efficacy of Prophylactic TAF for HBsAg-positive Patients Receiving bDMARDs

Safety, Tolerability, Pharmacokinetics and Antiviral Activity of IONIS-HBVRx in Treatment-Naïve Patients With Chronic HBV Infection

Puglia HCV Micro-elimination Program

A Study to Evaluate Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Treatment-Naïve Hepatitis C Virus Genotype 1b-Infected Adults

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-Administration of ABT-493 and ABT-530 With and Without RBV in Subjects With Chronic Hepatitis C Virus (HCV) Genotypes 2, 3, 4, 5 or 6 Infection

A Study to Evaluate the Safety and Effect of Co-administration of ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Adults With Chronic Hepatitis C Virus Infection

Clinical Trial to Evaluate the Efficacy and Safety of TenofoBell® Tablet in Chronic Hepatitis B Patients

Comparison of Immunization Schedules of Inactivated Hepatitis A Vaccine and Combined Hepatitis A and Hepatitis B Vaccine

Comparing the Effects of Vitamin E, Ursodeoxycholic Acid and Pentoxyfylline on Egyptian Non-alcoholic Steatohepatitis (NASH) Patients

Truenat™ HCV RNA Assay Evaluation

Understanding and Intervening With Heavy Drinking Among Patients With HIV and HCV